Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Interest Expenses (2017 - 2018)

Cardiff Oncology (CRDF) has disclosed Interest Expenses for 7 consecutive years, with $232.0 as the latest value for Q4 2018.

  • Quarterly Interest Expenses fell 99.02% to $232.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $232.0 through Sep 2019, down 99.53% year-over-year, with the annual reading at $2000.0 for FY2020, N/A changed from the prior year.
  • Interest Expenses hit $232.0 in Q4 2018 for Cardiff Oncology, up from $16.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $392414.0 in Q4 2015 to a low of $16.0 in Q3 2018.
  • Historically, Interest Expenses has averaged $158906.0 across 4 years, with a median of $37123.0 in 2017.
  • Biggest five-year swings in Interest Expenses: skyrocketed 8090.72% in 2014 and later plummeted 99.96% in 2018.
  • Year by year, Interest Expenses stood at $389871.0 in 2014, then grew by 0.65% to $392414.0 in 2015, then tumbled by 93.96% to $23683.0 in 2017, then crashed by 99.02% to $232.0 in 2018.
  • Business Quant data shows Interest Expenses for CRDF at $232.0 in Q4 2018, $16.0 in Q3 2018, and $925.0 in Q2 2018.